Is Seaport Therapeutics, Inc. Common Stock (SPTX) a Buy, Sell, or Hold?
NASDAQ : SPTX
Seaport Therapeutics, Inc. Common Stock
$20.85 USD
$1.33 (6.81%)
- Volume
- 71.07K
- Average Volume
- 359.64K
- Market Capitalization
- $1.12B
- P/E Ratio
- -10.75
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $23.00
- Year Low
- $14.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $17.46
Company Overview
NASDAQ
Daphne Zohar
Biotechnology
Healthcare
SPTX
58
US
USD
Liquidity Metrics
-0.05
17.46
17.46
3.60
0.00
Sales & Valuation
-$
0.00
-8.71
-14.25
-2.03
Profitability
-$1.94
-$74.88M
0.00%
0.00%
80.91%
-30.07%
P/E Metrics
-10.75
-0.11
-0.11
Analyst Price Target & Rating
$40.00
$50.00
$30.00
2/5
0 Analysts
-47.88%
Poll Results
About Seaport Therapeutics, Inc. Common Stock (NASDAQ:SPTX) Stock
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the c ... ompany connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
2026-06-09 03:00:00
[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and tra
2026-06-09 02:00:00
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™.
2026-06-08 08:00:00
[url="]Seaport Therapeutics, Inc.[/url], (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company that is inventing and devel
2026-06-08 08:00:00
[url="]Seaport Therapeutics, Inc.[/url], (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company that is inventing and devel
2026-06-08 07:05:00
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.
2026-06-08 07:00:00
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers.
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
2026-06-01 08:00:00
[url="]Seaport Therapeutics, Inc.,[/url] (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company that is inventing and devel
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
2026-06-01 07:00:00
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics to participate in two upcoming investor conferences.
Frequently Asked Questions
-
What is the current Seaport Therapeutics, Inc. Common Stock (SPTX) stock price?
-
Seaport Therapeutics, Inc. Common Stock(NASDAQ:SPTX) stock price is $20.85 in the last trading session. During the trading session, SPTX stock reached the peak price of $23 while $14.85 was the lowest point it dropped to. The percentage change in SPTX stock occurred in the recent session was 6.81% while the dollar amount for the price change in SPTX stock was $1.33.
-
SPTX's industry and sector of operation?
-
The NASDAQ listed SPTX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of SPTX?
-
Lana Gladstein | General Counsel
Antony Loebel | Chief Medical Officer & President of Clinical Development
Daphne Zohar | Founder, CEO, President & Director
Michael C. Chen | Co-Founder & Chief Scientific Officer
Lauren A. White | Chief Financial Officer -
How many employees does SPTX have?
-
Number of SPTX employees currently stands at 58. SPTX operates from 101 Seaport Blvd., Boston, MA 02210-2186, US.
-
Link for SPTX official website?
-
Official Website of SPTX is: https://www.seaporttx.com
-
How do I contact SPTX?
-
SPTX could be contacted at phone #(617) 807-4062 and can also be accessed through its website. SPTX operates from 101 Seaport Blvd., Boston, MA 02210-2186, US.
-
How many shares of SPTX are traded daily?
-
The average number of SPTX shares traded daily for last 3 months was 359.64K.
-
What is the market cap of SPTX currently?
-
The market value of SPTX currently stands at $1.12B with its latest stock price at $20.85